Skye Bioscience

Emerald Bioscience is a biopharmaceutical company dedicated to discovering and designing proprietary cannabinoid derivatives from a class of chemically diverse compounds known as cannabinoids, for the treatment of glaucoma and other diseases with significant unmet medical needs. Our innovative approach to drug development enables us to transform cannabinoids into safer and more effective therapeutic agents. By advancing our novel drugs, we are striving to bring important new medicines to market by unlocking the potential of cannabinoids.